نمایش پرونده ساده آیتم

dc.contributor.advisorPourlak, Tala
dc.contributor.authorYazdchi Sheshgelani, Nasim
dc.date.accessioned2020-08-03T09:58:12Z
dc.date.available2020-08-03T09:58:12Z
dc.date.issued2019en_US
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/62240
dc.description.abstractAccordingly in this study, the expression of Immunohistochemical markers (Galectin3, HBME-1, CK19) in benign and malignant thyroid lesion was assessed.Material and Methods: In this diagnostic study, 48 thyroid slides (34 benign and 14 malignant) under surgery in Imam-Reza Hospital in Tabriz in 2015 and 2016 were assessed and expression of Immunohistochemical markers (Galectin3, HBME-1, CK19) in thyroid lesion were evaluated and compared between benign a nd malignant groups.Results: HBME1 had sensitivity and specificity of 94.1% and 42.9%, respectively (P=0.005), Galectin3 had sensitivity and specificity of 100% and 42.9%, respectively (P=0.0001), and CK19 had sensitivity and specificity of 85.3% and 57.1%, respectively (P=0.005). FNA had sensitivity and specificity of 85.3% and 57.1%, respectively (P=0.005).en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Medicineen_US
dc.subjectThyroid malignancyen_US
dc.subjectHBME-1en_US
dc.subjectCK19en_US
dc.subjectGalectin3en_US
dc.subjectFNAen_US
dc.titleDiagnostic value of CK19, HBME1, GALECTIN3 for diagnosis of papillary thyroid carcinoma from FNA samplesen_US
dc.typeThesisen_US
dc.contributor.supervisorShokoohi, Behroz
dc.identifier.docno609554en_US
dc.identifier.callno9554en_US
dc.description.disciplinePathologyen_US
dc.description.degreeSpecialty Degreeen_US


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم